Girard Partners’s Boston Scientific BSX Stock Holding History

Girard Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-363	Closed	-$13K	–	314
2018 Q3	$13K	Buy	+363	New	+$12.7K	﹤0.01%	674

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Girard Partners's BSX Position: Q4 2018 in Review

Girard Partners sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 363 shares — an estimated $13K sold.

Girard Partners first reported a position in BSX in Q3 2018 and held it in 1 quarter. The position peaked at $13K in Q3 2018. 730 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

Girard Partners reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 363 Boston Scientific shares in Q4 2018, an estimated $13K.
Girard Partners first reported a position in Boston Scientific in Q3 2018 and held it in 1 quarter.
Girard Partners's Boston Scientific position peaked at $13K in Q3 2018.
730 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.